These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10198799)

  • 41. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin.
    Fellows PF; Linscott MK; Ivins BE; Pitt ML; Rossi CA; Gibbs PH; Friedlander AM
    Vaccine; 2001 Apr; 19(23-24):3241-7. PubMed ID: 11312020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs.
    Ivins BE; Fellows PF; Nelson GO
    Vaccine; 1994 Aug; 12(10):872-4. PubMed ID: 7975827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. US anthrax-vaccine producer saved for now.
    Morris K
    Lancet; 1998 Feb; 351(9103):657. PubMed ID: 9500344
    [No Abstract]   [Full Text] [Related]  

  • 44. Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.
    Tournier JN; Ulrich RG; Quesnel-Hellmann A; Mohamadzadeh M; Stiles BG
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):219-36. PubMed ID: 19254170
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The feasibility of using jet injector BIP-4 for immunization of laboratory animals with STI anthrax vaccine].
    Cherkasskii BL; Dzharylgasov SA; Skliarov VIa; Neliapin NM; Naumenko IuI
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):20-3. PubMed ID: 4207093
    [No Abstract]   [Full Text] [Related]  

  • 46. Human live anthrax vaccine in the former USSR.
    Shlyakhov EN; Rubinstein E
    Vaccine; 1994 Jun; 12(8):727-30. PubMed ID: 8091851
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Next-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA(-) (High Temperature Requirement A) Sterne Strain.
    Chitlaru T; Israeli M; Bar-Haim E; Elia U; Rotem S; Ehrlich S; Cohen O; Shafferman A
    Sci Rep; 2016 Jan; 6():18908. PubMed ID: 26732659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [On the 100th anniversary of L. S. Tsenkovskiĭ's development of the method of producing an attenuated vaccine against anthrax].
    Diachenko SS
    Mikrobiol Zh (1978); 1984; 46(6):93-6. PubMed ID: 6443874
    [No Abstract]   [Full Text] [Related]  

  • 49. Anthrax vaccine begins a new round of tests.
    Marshall E
    Science; 2002 Jan; 295(5554):427-9. PubMed ID: 11799216
    [No Abstract]   [Full Text] [Related]  

  • 50. Anthrax: the disease in relation to vaccines.
    Hambleton P; Carman JA; Melling J
    Vaccine; 1984 Jun; 2(2):125-32. PubMed ID: 6442500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunoproteomically identified GBAA_0345, alkyl hydroperoxide reductase subunit C is a potential target for multivalent anthrax vaccine.
    Kim YH; Kim KA; Kim YR; Choi MK; Kim HK; Choi KJ; Chun JH; Cha K; Hong KJ; Lee NG; Yoo CK; Oh HB; Kim TS; Rhie GE
    Proteomics; 2014 Jan; 14(1):93-104. PubMed ID: 24273028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of novel vaccines against anthrax in man.
    Stepanov AV; Marinin LI; Pomerantsev AP; Staritsin NA
    J Biotechnol; 1996 Jan; 44(1-3):155-60. PubMed ID: 8717399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anthrax: virulence and vaccines.
    Farrar WE
    Ann Intern Med; 1994 Sep; 121(5):379-80. PubMed ID: 8042830
    [No Abstract]   [Full Text] [Related]  

  • 54. Anthrax vaccines: a development update.
    Little SF
    BioDrugs; 2005; 19(4):233-45. PubMed ID: 16128606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine.
    Shakya KP; Hugh-Jones ME; Elzer PH
    Vaccine; 2007 Jul; 25(29):5374-7. PubMed ID: 17555849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potency testing of anthrax spore vaccine (living) in guinea pigs.
    Jaiswal TN; Mittal KR
    Indian Vet J; 1979 Mar; 56(3):199-201. PubMed ID: 113339
    [No Abstract]   [Full Text] [Related]  

  • 57. Experts focus on infective agents of bioterrorism.
    Stephenson J
    JAMA; 2002 Feb; 287(5):575-6. PubMed ID: 11829676
    [No Abstract]   [Full Text] [Related]  

  • 58. Adaptation to environment--the Pasteur anthrax vaccine in Australia.
    Todd JH
    Aust Vet J; 1992 Dec; 69(12):318-21. PubMed ID: 1492828
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunizing activity of oil adjuvant attenuated spore vaccine of Bacillus anthracis in sheep.
    Al-Dabbass AH; Al-Abdali SM; Mahmoud AA; Muhamed MM
    Zentralbl Veterinarmed B; 1986 Jun; 33(5):340-5. PubMed ID: 3096031
    [No Abstract]   [Full Text] [Related]  

  • 60. [Vaccination strategies for anthrax prevention].
    Beyer W
    Berl Munch Tierarztl Wochenschr; 2004; 117(11-12):508-24. PubMed ID: 15584433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.